{
    "2018-12-12": [
        [
            {
                "time": "2018-12-12",
                "original_text": "Why Arrowhead Pharmaceuticals Surged 11% Higher Today",
                "features": {
                    "keywords": [
                        "Arrowhead Pharmaceuticals",
                        "Surged",
                        "11%"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "none"
                }
            },
            {
                "time": "2018-12-12",
                "original_text": "Johnson & Johnson (JNJ) Gains But Lags Market: What You Should Know",
                "features": {
                    "keywords": [
                        "Johnson & Johnson",
                        "Gains",
                        "Lags Market"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2018-12-12",
                "original_text": "J&J Reportedly Willing To Pay $400 Million-Plus In Hip-Device Cases",
                "features": {
                    "keywords": [
                        "J&J",
                        "$400 Million",
                        "Hip-Device Cases"
                    ],
                    "sentiment_score": -0.7,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "none"
                }
            },
            {
                "time": "2018-12-12",
                "original_text": "J&J says its psoriasis drug superior to Novartis treatment in study",
                "features": {
                    "keywords": [
                        "J&J",
                        "psoriasis drug",
                        "superior",
                        "Novartis"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "none"
                }
            },
            {
                "time": "2018-12-12",
                "original_text": "5 Pharma Stocks That Could Cure Ailing Portfolios in 2019",
                "features": {
                    "keywords": [
                        "Pharma Stocks",
                        "Cure",
                        "Ailing Portfolios",
                        "2019"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "none",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-12-12",
                "original_text": "Health Care Sector Update for 12/12/2018: XBIT, SGYP, NBIX, MRNS, JNJ, PFE, MRK, ABT, AMGN",
                "features": {
                    "keywords": [
                        "Health Care Sector",
                        "Update",
                        "XBIT",
                        "SGYP",
                        "NBIX",
                        "MRNS",
                        "JNJ",
                        "PFE",
                        "MRK",
                        "ABT",
                        "AMGN"
                    ],
                    "sentiment_score": 0.5,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "none",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-12-12",
                "original_text": "Portola (PTLA) Down as CHMP Defers Review Date for Ondexxya",
                "features": {
                    "keywords": [
                        "Portola",
                        "Down",
                        "CHMP",
                        "Defers",
                        "Review Date",
                        "Ondexxya"
                    ],
                    "sentiment_score": -0.8,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "none"
                }
            },
            {
                "time": "2018-12-12",
                "original_text": "Here's How to Survive a Stock Market Crash",
                "features": {
                    "keywords": [
                        "Survive",
                        "Stock Market Crash"
                    ],
                    "sentiment_score": -0.6,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [],
                    "causal_factor": "false",
                    "causal_impact": "none",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2018-12-12",
                "original_text": "Do Analysts See Any Upside for Regeneron Stock?",
                "features": {
                    "keywords": [
                        "Analysts",
                        "Upside",
                        "Regeneron Stock"
                    ],
                    "sentiment_score": 0.4,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "none",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-12-12",
                "original_text": "What Regeneron Pharmaceuticalsâ€™ Bottom Line Indicates",
                "features": {
                    "keywords": [
                        "Regeneron Pharmaceuticals",
                        "Bottom Line"
                    ],
                    "sentiment_score": 0.3,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "none"
                }
            }
        ]
    ]
}